MyAverix Finance
LSE · Healthcare
Theracryf Plc (TCF)
Biotechnology
Theracryf Plc (TCF) is listed on LSE in the Healthcare sector. Industry: Biotechnology. As of 2026-05-19, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TCF
Theracryf Plc (TCF) — FAQ
What is TCF's P/E ratio?
The price-to-earnings (P/E) ratio for Theracryf Plc (TCF) is 25.00 (data as of 2026-05-19).
Does Theracryf Plc pay a dividend?
Dividend yield is not available in the current snapshot for Theracryf Plc (TCF). Check the MyAverix Finance app for the latest dividend data.
What sector is Theracryf Plc in?
Theracryf Plc (TCF) is classified in the Healthcare sector (Biotechnology industry).
What exchange is TCF listed on?
TCF is listed on LSE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.